Heart failure
Thrombin inhibition no help in worsening heart failure: COMMANDER HF
Low-dose rivaroxaban failed to improve outcomes in patients with worsening heart failure, reduced ejection fraction, and underlying coronary disease without atrial fibrillation in the COMMANDER HF trial.
The trial involved over 5,000 patients from 628 sites...
Low-dose rivaroxaban failed to improve outcomes in patients with worsening heart failure, reduced ejection fraction, and underlying coronary...